Open database of authors and journals




Results 1 to 20 of 1,702 articles found
2021

[Communication] Chronic hydroxychloroquine exposure and the risk of Alzheimer’s disease

2020

[Communication] Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: ‘Does hydroxychloroquine prevent the transmission of COVID-19?’ by Heldwein and Calado and ‘SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment’ by Joob and Wiwanitkit

2020

[Communication] Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis

2021

AB0456 HYDROXYCHLOROQUINE MIGHT REDUCE MORTALITY IN PATIENTS WITH SYSTEMIC SCLEROSIS

Annals of the Rheumatic Diseases (2.3 256★★), 80, 1255.1-1255. [Citation Report]
2020

AB0393 EFFICACY OF HYDROXYCHLOROQUINE FOR LUPUS NEPHRITIS IN MAINTENANCE PHASE

Annals of the Rheumatic Diseases (2.3 256★★), 79, 1496.2-1496. [Citation Report]
2020

AB0392 THE EFFECT OF HYDROXYCHLOROQUINE ON THE RISK FACTORS FOR ATHEROSCLEROSIS DEVELOPMENT

Annals of the Rheumatic Diseases (2.3 256★★), 79, 1496.3-1496. [Citation Report]
2019

[Communication] Chronic hydroxychloroquine/chloroquine exposure for connective tissue diseases and risk of Alzheimer’s disease

2020

[Communication] Correspondence on ': hydroxychloroquine, COVID-19 and the role of the rheumatologist' by Graef

2020

[Communication] Treatment of systemic lupus erythematosus: don’t forget hydroxychloroquine

2015

THU0345 Screening for Reversible Hydroxychloroquine-Related Ocular Toxicity Using an Amsler Grid

Annals of the Rheumatic Diseases (2.3 256★★), 74, 320.2-320. [Citation Report]
2021

[Communication] COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine

2018

[Communication] Cardiovascular effects of hydroxychloroquine: a systematic review and meta-analysis

2007

Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)

Annals of the Rheumatic Diseases (2.3 256★★), 66, 1168-72. [Citation Report]
2020

AB0371 HYDROXYCHLOROQUINE AS VIEWED BY LUPUS PATIENTS – WHAT IMPACT FOR DOCTORS?

Annals of the Rheumatic Diseases (2.3 256★★), 79, 1485.1-1486. [Citation Report]
2020

[Communication] Prevention of infections in patients with antineutrophil cytoplasm antibody-associated vasculitis: potential role of hydroxychloroquine

2007

[Communication] Relationship between blood hydroxychloroquine and desethylchloroquine concentrations and cigarette smoking in treated patients with connective tissue diseases

Annals of the Rheumatic Diseases (2.3 256★★), 66, 1547-8. [Citation Report]
2013

FRI0274 Hydroxychloroquine down-regulates interferon-alfa elevation through tlr-9 recognition of nucleotides which is irresponsive to glucocorticoid

Annals of the Rheumatic Diseases (2.3 256★★), 72, A467.1-A467. [Citation Report]
2021

[Communication] No evidence so far on the protective effect of hydroxychloroquine to prevent COVID-19: comment by Joob and Wiwanitkit

2021

OP0133 THE PREVALENCE AND RISK FACTORS OF RETINAL TOXICITY ASSOCIATED WITH LONG-TERM HYDROXYCHLOROQUINE USE

2020

Response to: ‘Treatment of systemic lupus erythematosus: don’t forget hydroxychloroquine’ by Michaud et al

Anatomy of Results
The left numbers are the publication year, and the number of citations (hyperlink to the full citation report of the paper)
paranthesis after the journal provides its impact factor.
paranthesis after the author indicates the number of publications and Author's Impact Factor
EXALY
Authors
Journals
Institutions
Fields